New and newly updated reports from the Congressional Research Service that Congress has declined to make available to the public online include the following.
Mexico’s Oil and Gas Sector: Background, Reform Efforts, and Implications for the United States, November 18, 2013
U.S.-Mexico Water Sharing: Background and Recent Developments, November 19, 2013
Interstate Natural Gas Pipelines: Process and Timing of FERC Permit Application Review, November 19, 2013
Cancellation of Nongroup Health Insurance Policies, November 19, 2013
Preserving Homeownership: Foreclosure Prevention Initiatives, November 20, 2013
The Federal Communications Commission: Current Structure and Its Role in the Changing Telecommunications Landscape, November 18, 2013
U.S.-China Military Contacts: Issues for Congress, November 20, 2013
Central Asia: Regional Developments and Implications for U.S. Interests, November 20, 2013
Algeria: Current Issues, November 18, 2013
U.S. Textile Manufacturing and the Trans-Pacific Partnership Negotiations, November 20, 2013
As surrogate markers are increasingly being accepted by FDA to support approval of new drugs and biologics, it is imperative that patients and clinicians understand whether such novel endpoints are reflective of meaningful clinical benefits.
The Secretary of Health and Human Services should launch a Department-wide initiative to reduce wasteful spending on health services, drugs, and ineffective medical devices, saving many lives as well as billions of dollars annually.
Now that the One Big Beautiful Bill is law, the elimination of clean energy tax credits will cause a nation of higher energy bills – even for consumers and states that aren’t using clean energy.
Bureaucracy significantly hinders federally funded scientific research, diverting scientists’ time from discovery to low-value administrative tasks.